Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs
|Cardiovascular Diseases||Other: intensive implementation programme Other: control|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs. A Randomized Trial.|
- The percentage of selected (=undertreated) patients receiving at least one prescription for lipid-lowering medication. [ Time Frame: six months after the general practitioner received the list with selected patients ]
- Differences in prescribing for age categories and co-medication. [ Time Frame: six months ]
|Study Start Date:||October 2006|
|Study Completion Date:||March 2008|
|Primary Completion Date:||February 2008 (Final data collection date for primary outcome measure)|
Other: intensive implementation programme
educational manual; interactive educational meeting tailored to individual needs; reminders and feedback by 3 newsletters and at least 3 telephone calls.
|Active Comparator: control||
Cardiovascular disease is the main cause of death in large parts of the world. Next to life style changes, pharmaceutical treatment is a keystone in the treatment of cardiovascular disease. Despite the strong evidence for the effectiveness of lipid-lowering therapy, less than half of the people eligible are treated. With specific medication searches in the community pharmacy database, an easy tool for detecting patients who are undertreated is available. Based on this tool, a pharmaceutical care model for improving underprescription and treatment persistence regarding lipid-lowering medication in patients with cardiovascular disease was constructed.
Moreover, it is not known yet how to implement this pharmaceutical care model in community pharmacies effectively. With multifaceted interventions the behaviour of health professionals can be changed. In this study the effectiveness of a maximal support strategy, including interactive educational meetings, reminders, audit and feedback, is compared to a minimal implementation strategy.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00509717
|UMC St Radboud, Scientific Institute for Quality of Healthcare|
|Nijmegen, NL, Netherlands, 6500 HB|
|Principal Investigator:||Peter G. de Smet, PhD||Radboud University|
|Study Director:||Michel Wensing, PhD||Scientific Institute for Quality of Healthcare|